📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
NEUTRAL
TOTAL VIEWS
25
ORGO Latest News & AI Sentiment Analysis
2 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 4 ARTICLES
Organogenesis Holdings Inc. (ORGO) Q2 2026 Earnings Call Transcript
ORGO's Q2 2026 earnings call represents a routine disclosure event typical of quarterly corporate communications. The transcript release...
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
Organogenesis (ORGO) published peer-reviewed clinical trial results demonstrating that its Affinity product, when combined with standard...
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Organogenesis Holdings (ORGO) announced its second quarter fiscal 2026 earnings release scheduled for August 6, 2026, after market...
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
Organogenesis (ORGO) achieved a significant regulatory milestone with FDA acceptance of its Biologics License Application for ReNu®, a...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice